Financhill
Back

Genscript Biotech Quote, Financials, Valuation and Earnings

Genscript Biotech Price Quote

$1.25

Genscript Biotech Key Stats

Buy
65
Genscript Biotech (GNNSF) is a Buy

Day range:
$1.25 - $1.25
52-week range:
$1.05 - $3.20
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
2.62
P/B ratio:
2.21%

Volume:
0
Avg. volume:
1.1K
1-year change:
-60.94%
Market cap:
$2.7B
Revenue:
$839.5M
EPS:
$-0.08

How Much Does Genscript Biotech Make?

Is Genscript Biotech Growing As A Company?

Data Unavailable

Genscript Biotech Stock Price Performance

What Is Genscript Biotech 52-Week High & Low?

Genscript Biotech Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Genscript Biotech?

  • How Much Debt Does Genscript Biotech Have?
    Total long term debt quarterly is $336.1M
  • How Much Cash Does Genscript Biotech Have?
    Cash and short term investments quarterly total is $1.9B
  • What Is Genscript Biotech’s Book Value Per Share?
    Book value per share is 0.57

Is Genscript Biotech Cash Flow Positive?

  • What Is GNNSF Cash Flow From Operations?
    Cash flow from operations (TTM) is -$19.9M
  • What Is Genscript Biotech’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $53.8M
  • What Is Genscript Biotech’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1B

Genscript Biotech Return On Invested Capital

  • Is Management Doing A Good Job?
    GNNSF return on invested capital is -7.65%
  • What Is Genscript Biotech Return On Assets?
    ROA measures how assets are converting to revenues and is -5.26%
  • What Is GNNSF Return On Equity?
    ROE is a measure of profitability and is -8.92%

Genscript Biotech Earnings Date & Stock Price

Genscript Biotech Competitors

  • Who Are Genscript Biotech's Competitors?
    Below is a list of companies who compete with Genscript Biotech or are related in some way:
    • Adagene Inc (ADAG)
    • CASI Pharmaceuticals Inc (CASI)
    • LakeShore Biopharma Co Ltd (LSB)
    • Sinovac Biotech Ltd (SVA)
    • Zai Lab Ltd (ZLAB)

Genscript Biotech Dividend Yield

Genscript Biotech Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 0
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 0.00
Downside from Last Price: -100%

Major Shareholders

  • How many GNNSF shares are owned by institutional investors?
    326.7M GNNSF shares are owned by institutional investors
  • How many GNNSF shares are owned by insiders?
    0 GNNSF shares are owned by insiders